Literature DB >> 10433489

Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes.

T Kobayashi1, K Kamata.   

Abstract

1. This study involved the chronic administration of low or high insulin to rats with established streptozotocin (STZ)-induced diabetes. We studied the effect of such treatment on smooth muscle contractility and endothelium-dependent relaxation using aortic strips. 2. Aortae from diabetic rats, but not those from high-insulin-treated diabetic rats, showed an impaired endothelium-dependent in response to acetylcholine (ACh) by comparison with untreated controls. 3. Isotonic high K+-induced contractility was impaired in diabetic aortae. This impairment was prevented by high-insulin treatment. 4. Noradrenaline (NA)-induced contractility was enhanced in aortae from high-insulin-treated diabetic rats, but not in those from untreated diabetic or low-insulin treated diabetic rats. 5. In the combined presence of the nitric oxide inhibitor N(G)-nitro-L-arginine and the cyclo-oxygenase inhibitor indomethacin, NA-induced contractility was significantly greater in aortae from high-insulin-treated diabetic rats than in those from controls or untreated diabetic rats. 6. An increased expression of the mRNA for the alpha1D and alpha1B adrenergic receptors was found in aortae from high-insulin-treated diabetic rats. 7. These results demonstrate that in rats with established STZ-induced diabetes, high-insulin treatment prevents the development of an impaired endothelium-dependent relaxation in the aorta, and that such treatment enhances NA-induced contractility. This enhancement may be related to an upregulation in the expression of the mRNA for the alpha1B or alpha1D adrenergic receptor that is secondary to the hyperinsulinaemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433489      PMCID: PMC1566078          DOI: 10.1038/sj.bjp.0702554

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Calmodulin glycation in diabetic rat lenses.

Authors:  N D Evcimen; S Nebioğlu
Journal:  Can J Physiol Pharmacol       Date:  1996-12       Impact factor: 2.273

2.  Insulin and insulin-like growth factor I differentially induce alpha1-adrenergic receptor subtype expression in rat vascular smooth muscle cells.

Authors:  Z W Hu; X Y Shi; B B Hoffman
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

3.  Divergent actions of chronic insulin treatment in vivo versus acute treatment ex vivo on diabetic-induced endothelial dysfunction.

Authors:  G M Pieper
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

4.  The effect of insulin treatment and of islet transplantation on the resistance artery function in the STZ-induced diabetic rat.

Authors:  K M Heygate; J Davies; M Holmes; R F James; H Thurston
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

5.  Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes.

Authors:  K Kamata; T Kobayashi
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

6.  Induction of insulin-like growth factor receptor (IGF IR) mRNA levels by low density lipoproteins.

Authors:  J I Polanco; M Albajar; M Pocoví; J C Rodríguez Rey
Journal:  Biochem Biophys Res Commun       Date:  1996-09-24       Impact factor: 3.575

7.  Insulin enhances endothelial alpha2-adrenergic vasorelaxation by a pertussis toxin mechanism.

Authors:  G Lembo; G Iaccarino; C Vecchione; E Barbato; C Morisco; F Monti; L Parrella; B Trimarco
Journal:  Hypertension       Date:  1997-11       Impact factor: 10.190

8.  Free radicals mediate endothelial cell dysfunction caused by elevated glucose.

Authors:  B Tesfamariam; R A Cohen
Journal:  Am J Physiol       Date:  1992-08

9.  Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans.

Authors:  C J Tack; J A Lutterman; G Vervoort; T Thien; P Smits
Journal:  Hypertension       Date:  1996-09       Impact factor: 10.190

10.  Preservation of endothelium-dependent relaxation in cholesterol-fed and streptozotocin-induced diabetic mice by the chronic administration of cholestyramine.

Authors:  K Kamata; M Sugiura; S Kojima; Y Kasuya
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more
  10 in total

Review 1.  Early diabetic neuropathy: triggers and mechanisms.

Authors:  Maxim Dobretsov; Dmitry Romanovsky; Joseph R Stimers
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

2.  Effects of chronic administration of the novel endothelin antagonist J-104132 on endothelial dysfunction in streptozotocin-induced diabetic rat.

Authors:  Noriyasu Kanie; Katsuo Kamata
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

3.  The effect of long-term streptozotocin-induced diabetes on contractile and relaxation responses of coronary arteries: selective attenuation of CGRP-induced relaxations.

Authors:  M Sheykhzade; G T Dalsgaard; T Johansen; N C Nyborg
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

4.  Hyper-reactivity of diacylglycerol kinase is involved in the dysfunction of aortic smooth muscle contractility in streptozotocin-induced diabetic rats.

Authors:  Koji Nobe; Yasushi Sakai; Yoshiaki Maruyama; Kazutaka Momose
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

5.  Possible involvement of IGF-1 receptor and IGF-binding protein in insulin-induced enhancement of noradrenaline response in diabetic rat aorta.

Authors:  Tsuneo Kobayashi; Akihito Kaneda; Katsuo Kamata
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

6.  Relationship between peroxisome proliferator-activated receptors (PPAR alpha and PPAR gamma) and endothelium-dependent relaxation in streptozotocin-induced diabetic rats.

Authors:  Noriyasu Kanie; Takayuki Matsumoto; Tsuneo Kobayashi; Katsuo Kamata
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

7.  Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK.

Authors:  T Kobayashi; T Nogami; K Taguchi; T Matsumoto; K Kamata
Journal:  Br J Pharmacol       Date:  2008-08-18       Impact factor: 8.739

8.  Increased cytochrome P4502E1 expression and altered hydroxyeicosatetraenoic acid formation mediate diabetic vascular dysfunction: rescue by guanylyl-cyclase activation.

Authors:  Andreas Schäfer; Paolo Galuppo; Daniela Fraccarollo; Christian Vogt; Julian D Widder; Julia Pfrang; Piet Tas; Eduardo Barbosa-Sicard; Hartmut Ruetten; Georg Ertl; Ingrid Fleming; Johann Bauersachs
Journal:  Diabetes       Date:  2010-06-03       Impact factor: 9.461

9.  Genipin and insulin combined treatment improves implant osseointegration in type 2 diabetic rats.

Authors:  Jiajia Zhang; Ya-Nan Wang; Tingting Jia; Haiyun Huang; Dongjiao Zhang; Xin Xu
Journal:  J Orthop Surg Res       Date:  2021-01-14       Impact factor: 2.359

10.  Role of ROCK upregulation in endothelial and smooth muscle vascular functions in diabetic rat aorta.

Authors:  Figen Amber Cicek; Hilmi B Kandilci; Belma Turan
Journal:  Cardiovasc Diabetol       Date:  2013-03-27       Impact factor: 9.951

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.